Medicine recalls
|
| |
| Canada: Recall: Sandoz Orphenadrine Tablet (Extended-Release) 100mg: Impurity |
| |
Health Canada announces that Sandoz Canada Inc is recalling 2 lots of Sandoz Orphenadrine Tablet (Extended-Release) 100mg (lot number: JY6254, JY6255) from retailers due to presence of impurity N-methyl-N-nitroso-2-[(2-methylphenyl)phenylmethoxy]ethanamine (NMOA) above the acceptable concentration limit in affected lots.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/sandoz-orphenadrine-impurity
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Thursday, Nov 4, 2021
Issued at HKT 14:00
|
| |
